MCID: GST029
MIFTS: 31

Gastric Cardia Adenocarcinoma

Categories: Cancer diseases, Gastrointestinal diseases

Aliases & Classifications for Gastric Cardia Adenocarcinoma

MalaCards integrated aliases for Gastric Cardia Adenocarcinoma:

Name: Gastric Cardia Adenocarcinoma 12 15 71
Adenocarcinoma of Cardia of Stomach 12
Adenocarcinoma of Gastric Cardia 12

Classifications:



External Ids:

Disease Ontology 12 DOID:6271
NCIt 49 C5247
UMLS 71 C1333762

Summaries for Gastric Cardia Adenocarcinoma

MalaCards based summary : Gastric Cardia Adenocarcinoma, also known as adenocarcinoma of cardia of stomach, is related to esophageal cancer and cardia cancer, and has symptoms including abdominal pain and dyspepsia. An important gene associated with Gastric Cardia Adenocarcinoma is HOTAIR (HOX Transcript Antisense RNA), and among its related pathways/superpathways is LncRNA-mediated mechanisms of therapeutic resistance. The drugs Trioxsalen and Dihematoporphyrin Ether have been mentioned in the context of this disorder. Affiliated tissues include lymph node, bone and lung.

Related Diseases for Gastric Cardia Adenocarcinoma

Diseases related to Gastric Cardia Adenocarcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 55, show less)
# Related Disease Score Top Affiliating Genes
1 esophageal cancer 32.2 TP53 SLC52A3 PLCE1 MTHFR MIR203A MEG3
2 cardia cancer 30.1 TP53 SLC52A3 SEMA3B-AS1 PLCE1 MTHFR MIR770
3 adenocarcinoma 11.0
4 helicobacter pylori infection 10.4
5 squamous cell carcinoma 10.4
6 lemierre's syndrome 10.4 MTHFR HOTAIR
7 functionless pituitary adenoma 10.3 MEG3 HOTAIR
8 barrett esophagus 10.3
9 gastric adenocarcinoma 10.3
10 gastritis 10.3
11 pregnancy loss, recurrent 1 10.3 MTHFR HOTAIR
12 gastric cardia carcinoma 10.3 NEDD4 MTHFR
13 gastroesophageal reflux 10.3
14 atrophic gastritis 10.3
15 marek disease 10.2 TP53 H19
16 thyroid cancer, nonmedullary, 1 10.2 MEG3 HOTAIR H19
17 body mass index quantitative trait locus 1 10.2
18 gastric cancer 10.2
19 esophagus squamous cell carcinoma 10.1 MEG3 HOTAIR
20 vulva squamous cell carcinoma 10.1 TP53 MEG3
21 wilms tumor predisposition 10.0 TP53 H19
22 hernia, hiatus 10.0
23 lung cancer 10.0
24 proteasome-associated autoinflammatory syndrome 1 10.0
25 body mass index quantitative trait locus 11 10.0
26 body mass index quantitative trait locus 9 10.0
27 body mass index quantitative trait locus 8 10.0
28 body mass index quantitative trait locus 4 10.0
29 body mass index quantitative trait locus 10 10.0
30 body mass index quantitative trait locus 7 10.0
31 body mass index quantitative trait locus 12 10.0
32 body mass index quantitative trait locus 14 10.0
33 body mass index quantitative trait locus 18 10.0
34 body mass index quantitative trait locus 19 10.0
35 body mass index quantitative trait locus 20 10.0
36 gastrointestinal carcinoma 10.0
37 hyperuricemia 10.0
38 palmoplantar keratosis 10.0
39 gastroesophageal junction adenocarcinoma 10.0
40 b-cell lymphoma 10.0
41 retinoblastoma 10.0
42 familial retinoblastoma 10.0
43 pituitary adenoma 10.0 MEG3 HOTAIR H19 GADD45G
44 glioma susceptibility 1 10.0 TP53 MEG3 HOTAIR H19
45 glioma 10.0 TP53 MEG3 HOTAIR H19
46 malignant glioma 9.9 TP53 MEG3 HOTAIR H19
47 laryngeal squamous cell carcinoma 9.9 TP53 HOTAIR H19
48 gallbladder cancer 9.9 TP53 MEG3 HOTAIR H19
49 pancreatic ductal adenocarcinoma 9.9 TP53 MIR203A HOTAIR H19
50 pituitary carcinoma 9.9 TP53 MEG3
51 osteogenic sarcoma 9.9 TP53 MEG3 HOTAIR H19
52 kidney cancer 9.8 TP53 MEG3 HOTAIR H19
53 oral squamous cell carcinoma 9.8 TP53 MIR203A MEG3 HOTAIR H19
54 leukemia, chronic myeloid 9.7 TP53 MIR203A MEG3 HOTAIR H19
55 bladder cancer 9.5 TP53 MIR203A MEG3 HOTAIR H19 C5orf66-AS1

Graphical network of the top 20 diseases related to Gastric Cardia Adenocarcinoma:



Diseases related to Gastric Cardia Adenocarcinoma

Symptoms & Phenotypes for Gastric Cardia Adenocarcinoma

UMLS symptoms related to Gastric Cardia Adenocarcinoma:


abdominal pain, dyspepsia

Drugs & Therapeutics for Gastric Cardia Adenocarcinoma

Drugs for Gastric Cardia Adenocarcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 40, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Trioxsalen Approved Phase 3 3902-71-4 5585
2 Dihematoporphyrin Ether Phase 3
3 Photosensitizing Agents Phase 3
4 Hematoporphyrins Phase 3
5 Dermatologic Agents Phase 3
6 Hematoporphyrin Derivative Phase 3
7 Ether Phase 3
8
Lapatinib Approved, Investigational Phase 2 231277-92-2, 388082-78-8 208908 9941095
9
Capecitabine Approved, Investigational Phase 2 154361-50-9 60953
10
Docetaxel Approved, Investigational Phase 2 114977-28-5 148124
11
Fluorouracil Approved Phase 1, Phase 2 51-21-8 3385
12
leucovorin Approved Phase 1, Phase 2 58-05-9 6006 143
13
Oxaliplatin Approved, Investigational Phase 1, Phase 2 61825-94-3 43805 6857599 5310940 9887054
14
Levoleucovorin Approved, Investigational Phase 1, Phase 2 68538-85-2
15
Pembrolizumab Approved Phase 1, Phase 2 1374853-91-4
16
Paclitaxel Approved, Vet_approved Phase 1, Phase 2 33069-62-4 36314
17
Carboplatin Approved Phase 1, Phase 2 41575-94-4 10339178 38904 498142
18
Folic acid Approved, Nutraceutical, Vet_approved Phase 1, Phase 2 59-30-3 6037
19 Protein Kinase Inhibitors Phase 2
20
Erlotinib Hydrochloride Phase 2 183319-69-9 176871
21 Micronutrients Phase 1, Phase 2
22 Trace Elements Phase 1, Phase 2
23 Vitamins Phase 1, Phase 2
24 Antidotes Phase 1, Phase 2
25 Vitamin B Complex Phase 1, Phase 2
26 Nutrients Phase 1, Phase 2
27 Folate Phase 1, Phase 2
28 Protective Agents Phase 1, Phase 2
29 Vitamin B9 Phase 1, Phase 2
30 Immunologic Factors Phase 1, Phase 2
31 Albumin-Bound Paclitaxel Phase 1, Phase 2
32 Hormones Phase 1, Phase 2
33 Hematinics Phase 1, Phase 2
34 Immunosuppressive Agents Phase 1, Phase 2
35 Tubulin Modulators Phase 1, Phase 2
36 Calcium, Dietary Phase 1, Phase 2
37 Antimitotic Agents Phase 1, Phase 2
38 Antimetabolites Phase 1, Phase 2
39 Antineoplastic Agents, Immunological Phase 1, Phase 2
40
Calcium Nutraceutical Phase 1, Phase 2 7440-70-2 271

Interventional clinical trials:

(showing 7, show less)
# Name Status NCT ID Phase Drugs
1 Two-arm Phase III Trial Comparing Different Time of Endoscopic Photodynamic Therapy on Esophageal and/or Gastric Cardiac Cancer Unknown status NCT02628665 Phase 3 photosensitizer(photofrin)
2 A Phase II, Open-Label Study Evaluating Clinical Efficacy, Safety, Pharmacokinetic and Pharmacodynamic Effects of Lapatinib (GW572016) in Patients With Relapsed Adenocarcinoma of the Esophagus, Including Tumors of the Gastroesophageal Junction and Gastric Cardia Completed NCT00259987 Phase 2 Lapatinib (GW572016) oral tablets
3 A Phase II Study of Erlotinib and Modified FOLFOX-6 (5-Fluorouracil, Leucovorin and Oxaliplatin) in Previously Untreated Patients With Unresectable or Metastatic Adenocarcinoma of the Esophagus and Gastric Cardia Completed NCT00591123 Phase 2 FOLFOX and Erlotinib
4 Randomized Phase II Trial of Extended Neoadjuvant Therapy for Locally Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, and Gastric Cardia Completed NCT00938470 Phase 2 capecitabine;docetaxel;fluorouracil;oxaliplatin
5 Phase 1b/2 Clinical Trial of Neoadjuvant Pembrolizumab Plus Concurrent Chemoradiotherapy With Weekly Carboplatin and Paclitaxel in Adult Patients With Resectable, Locally Advanced Adenocarcinoma of the Gastroesophageal Junction or Gastric Cardia Recruiting NCT02730546 Phase 1, Phase 2 Carboplatin;Fluorouracil;Leucovorin Calcium;Oxaliplatin;Paclitaxel
6 A Phase II Trial of Modified FOLFOX-6 Induction Chemotherapy Followed by Esophagectomy and Post-operative Response Based Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Adenocarcinoma of the Esophagus, Gastro-esophageal Junction, and Gastric Cardia Recruiting NCT02037048 Phase 2 oxaliplatin;leucovorin calcium;fluorouracil;carboplatin;paclitaxel
7 Prevalence of Dysplasia of the Gastric Cardia Completed NCT01787864

Search NIH Clinical Center for Gastric Cardia Adenocarcinoma

Genetic Tests for Gastric Cardia Adenocarcinoma

Anatomical Context for Gastric Cardia Adenocarcinoma

MalaCards organs/tissues related to Gastric Cardia Adenocarcinoma:

40
Lymph Node, Bone, Lung, T Cells, Endothelial, Neutrophil

Publications for Gastric Cardia Adenocarcinoma

Articles related to Gastric Cardia Adenocarcinoma:

(showing 281, show less)
# Title Authors PMID Year
1
Clinical profile of patients presenting with dysphagia - an experience from a tertiary care center in North India. 61
32514456 2020
2
Serum ghrelin and esophageal and gastric cancer in two cohorts in China. 61
31351006 2020
3
MiR-638 regulates gastric cardia adenocarcinoma cell proliferation, apoptosis, migration and invasion by targeting MACC1. 61
32064885 2020
4
Epigenetically silenced PD-L1 confers drug resistance to anti-PD1 therapy in gastric cardia adenocarcinoma. 61
32088639 2020
5
Gastric Cardia Adenocarcinoma with Metastasis to the Scalp: A Case Report. 61
32140341 2020
6
A clinical metabolomics-based biomarker signature as an approach for early diagnosis of gastric cardia adenocarcinoma. 61
31897184 2020
7
Helicobacter pylori Is Associated With Precancerous and Cancerous Lesions of the Gastric Cardia Mucosa: Results of a Large Population-Based Study in China. 61
32195175 2020
8
Serologic Profile of Antiparietal Cell Antibodies, Pepsinogens, and H. pylori and Risk of Upper Gastrointestinal Cancer: A Nested Case-Control Study in China. 61
31501152 2019
9
A Comparison of Biopsy and Mucosal Swab Specimens for Examining the Microbiota of Upper Gastrointestinal Carcinoma. 61
31519703 2019
10
Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China. 61
31355925 2019
11
Interaction of 22 risk SNPs with Helicobacter pylori infection and risk of gastric cardia adenocarcinoma. 61
31650851 2019
12
[The association of Bcl-2 gene polymorphism with the esophageal cancer and gastric cardia adenocarcinoma in Hebei Province]. 61
31683398 2019
13
Genetic variations associated with telomere length confer risk of gastric cardia adenocarcinoma. 61
30900102 2019
14
MiR-718 mediates the indirect interaction between lncRNA SEMA3B-AS1 and PTEN to regulate the proliferation of hepatocellular carcinoma cells. 61
31251699 2019
15
Overweight Patterns Between Childhood and Early Adulthood and Esophageal and Gastric Cardia Adenocarcinoma Risk. 61
31380608 2019
16
Time trends in the incidence of esophageal adenocarcinoma, gastric adenocarcinoma, and superficial esophagogastric junction adenocarcinoma. 61
30927083 2019
17
Mediterranean diet adherence and risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study. 61
30771119 2019
18
MiR-6872 host gene SEMA3B and its antisense lncRNA SEMA3B-AS1 function synergistically to suppress gastric cardia adenocarcinoma progression. 61
30656427 2019
19
Local and Systemic IL-7 Concentration in Gastrointestinal-Tract Cancers. 61
31185636 2019
20
Circumferential Endoscopic Submucosal Tunnel Dissection of Gastric Cardia Adenocarcinoma. 61
31620500 2019
21
Incidence Trends of Esophageal and Gastric Cancer Subtypes by Race, Ethnicity, and Age in the United States, 1997-2014. 61
29902641 2019
22
Hypoglycemia caused by co-secretion of insulin from lung tumor and cardia cancer: first case report. 61
29166433 2019
23
Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Esophageal/Gastric Cardia Adenocarcinoma Among Men. 61
29788475 2019
24
The Hippo signaling effector WWTR1 is a metastatic biomarker of gastric cardia adenocarcinoma. 61
30976198 2019
25
Alcohol consumption and risk of gastric cardia adenocarcinoma and gastric noncardia adenocarcinoma: A 16-year prospective analysis from the NIH-AARP diet and health cohort. 61
29992560 2018
26
Tree nut, peanut, and peanut butter consumption and the risk of gastric and esophageal cancer subtypes: the Netherlands Cohort Study. 61
29594821 2018
27
Leukocyte telomere length and risk of gastric cardia adenocarcinoma. 61
30275518 2018
28
Aberrant methylation-mediated downregulation of long noncoding RNA C5orf66-AS1 promotes the development of gastric cardia adenocarcinoma. 61
29566283 2018
29
Periurethral Mass Mimicking Neoplasm After Injection of Macroplastique for Postprostatectomy Stress Incontinence: A Pitfall on 18F-FDG PET/CT. 61
29517541 2018
30
MicroRNA-141 inhibits proliferation of gastric cardia adenocarcinoma by targeting MACC1. 61
29765447 2018
31
Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma. 61
30198863 2018
32
A pooled analysis of dietary sugar/carbohydrate intake and esophageal and gastric cardia adenocarcinoma incidence and survival in the USA. 61
29040685 2017
33
Expression of TGF-b and CD-44 in age specific subgroup of patients with adenocarcinoma of gastric cardia. 61
31952750 2017
34
Association of high-evidence gastric cancer susceptibility loci and somatic gene expression levels with survival. 61
29028942 2017
35
Nut and peanut butter consumption and the risk of esophageal and gastric cancer subtypes. 61
28768652 2017
36
CyclinD1 and p57kip2 as biomarkers in differentiation, metastasis and prognosis of gastric cardia adenocarcinoma. 61
29088752 2017
37
Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma. 61
28345805 2017
38
Body mass index and risk of gastric cancer: A 30-year follow-up study in the Linxian general population trial cohort. 61
28594442 2017
39
Gastric microbiota features associated with cancer risk factors and clinical outcomes: A pilot study in gastric cardia cancer patients from Shanxi, China. 61
28319273 2017
40
Clinicopathological features of Siewert type II adenocarcinoma: comparison of gastric cardia adenocarcinoma and Barrett's esophageal adenocarcinoma following endoscopic submucosal dissection. 61
27783167 2017
41
Abdominal obesity and gastroesophageal cancer risk: systematic review and meta-analysis of prospective studies. 61
28336766 2017
42
Impact of TGF-b and CD-44 for the benefit of radical surgery in elderly patients with adenocarcinoma of gastric cardia. 61
32135922 2017
43
Postoperative Eyelid Metastasis of a Gastric Cardia Adenocarcinoma. 61
28469215 2017
44
Red and processed meat consumption and gastric cancer risk: a systematic review and meta-analysis. 61
28430644 2017
45
Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies. 61
28196067 2017
46
Association of genotypes of rs671 withinALDH2 with risk for gastric cardia adenocarcinoma in the Chinese Han population in high- and low-incidence areas. 61
28443204 2017
47
Association of Genetic Polymorphisms in the LncRNAs with Gastric Cancer Risk in a Chinese Population. 61
28367233 2017
48
Adenocarcinoma risk in patients registered with Polish Barrett's Oesophagus Registry. 61
27377059 2017
49
Comparative analysis of gene expression profiles of gastric cardia adenocarcinoma and gastric non-cardia adenocarcinoma. 61
27895742 2016
50
Downregulation of Potential Tumor Suppressor miR-203a by Promoter Methylation Contributes to the Invasiveness of Gastric Cardia Adenocarcinoma. 61
27791400 2016
51
Decreased expression and frequent promoter hypermethylation of RASSF2 and RASSF6 correlate with malignant progression and poor prognosis of gastric cardia adenocarcinoma. 61
26456015 2016
52
Barrett's Mucosa Segmentation in Endoscopic Images Using a Hybrid Method: Spatial Fuzzy c-mean and Level Set. 61
28028499 2016
53
Etiology and Prevention of Esophageal Cancer. 61
27722152 2016
54
XPG Gene Polymorphisms and the Risk of Gastric Cardia Adenocarcinoma. 61
27228234 2016
55
Expression of CDX2 in gastric cardia adenocarcinoma and its correlation with H. pylori and cell proliferation. 61
27384681 2016
56
Aberrant CpG Island Shore Region Methylation of CAV1 Is Associated with Tumor Progression and Poor Prognosis in Gastric Cardia Adenocarcinoma. 61
27986126 2016
57
Gastric cardia adenocarcinoma microRNA profiling in Chinese patients. 61
26781873 2016
58
Methylation-mediated downregulation of long noncoding RNA LOC100130476 in gastric cardia adenocarcinoma. 61
27189370 2016
59
Reduced MUTYH, MTH1, and OGG1 expression and TP53 mutation in diffuse-type adenocarcinoma of gastric cardia. 61
26980051 2016
60
CYR61 (CCN1) is a metastatic biomarker of gastric cardia adenocarcinoma. 61
27105510 2016
61
Genomic Landscape of Somatic Alterations in Esophageal Squamous Cell Carcinoma and Gastric Cancer. 61
26857264 2016
62
Investigation of Cytotoxic T-lymphocyte antigen 4 Polymorphisms in Gastric Cardia Adenocarcinoma. 61
26709093 2016
63
Dietary Flavonols Intake and Risk of Esophageal and Gastric Cancer: A Meta-Analysis of Epidemiological Studies. 61
26891324 2016
64
Metabolic syndrome and esophageal and gastric cancer. 61
26450604 2015
65
DNA methylation inhibitor, decitabine, promotes MGC803 gastric cancer cell migration and invasion via the upregulation of NEDD4‑1. 61
26458406 2015
66
Decreased expression and aberrant methylation of RASSF5A correlates with malignant progression of gastric cardia adenocarcinoma. 61
25420558 2015
67
Correlation among RKIP expression, NF-κB p65 levels, and T-lymphocyte subsets in gastric cardia adenocarcinoma. 61
26662448 2015
68
General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition. 61
25598323 2015
69
Genome-wide association pathway analysis to identify candidate single nucleotide polymorphisms and molecular pathways for gastric adenocarcinoma. 61
25687184 2015
70
Esophageal Squamous Cell Carcinoma and Gastric Cardia Adenocarcinoma Shared Susceptibility Locus in C20orf54: Evidence from Published Studies. 61
26154995 2015
71
Down-regulation of C/EBP homologous protein (CHOP) expression in gastric cardia adenocarcinoma: Their relationship with clinicopathological parameters and prognostic significance. 61
25582300 2015
72
Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma. 61
24612004 2015
73
PSCA s2294008 C>T and rs2976392 G>A polymorphisms contribute to cancer susceptibility: evidence from published studies. 61
26124924 2015
74
Associations between polymorphisms of HOTAIR and risk of gastric cardia adenocarcinoma in a population of north China. 61
25476857 2015
75
Variant TP53BP1 rs560191 G>C is associated with risk of gastric cardia adenocarcinoma in a Chinese Han population. 61
25937777 2015
76
p21, p53, TP53BP1 and p73 polymorphisms and the risk of gastric cardia adenocarcinoma in a Chinese population. 61
25532599 2015
77
Clinicopathological features and prognosis of gastric cardia adenocarcinoma: a multi-institutional US study. 61
25308915 2015
78
Dietary intake of flavonoids and oesophageal and gastric cancer: incidence and survival in the United States of America (USA). 61
25668011 2015
79
Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers. 61
26445463 2015
80
Two distinct etiologies of gastric cardia adenocarcinoma: interactions among pH, Helicobacter pylori, and bile acids. 61
26029176 2015
81
What is Obesity Doing to Your Gut? 61
25892944 2015
82
Obesity and related risk factors in gastric cardia adenocarcinoma. 61
25209115 2015
83
Programmed death-1 (PD-1) polymorphism is associated with gastric cardia adenocarcinoma. 61
26221374 2015
84
Genetic variations in MTHFR and gastric cardia adenocarcinoma susceptibility in the Chinese Han population. 61
26770518 2015
85
FBXO32, a new TGF-β/Smad signaling pathway target gene, is epigenetically inactivated in gastric cardia adenocarcinoma. 61
25997968 2015
86
RANK rs1805034 T>C Polymorphism Is Associated with Susceptibility to Gastric Cardia Adenocarcinoma in a Chinese Population. 61
26451891 2015
87
Identification of a novel gene fusion (BMX-ARHGAP) in gastric cardia adenocarcinoma. 61
25499959 2014
88
[Prognostic value of blood neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with gastric cancer]. 61
25623765 2014
89
Nedd4-1 is an exceptional prognostic biomarker for gastric cardia adenocarcinoma and functionally associated with metastasis. 61
25395181 2014
90
Polymorphisms of MTHFR and susceptibility to oesophageal adenocarcinoma in a Caucasian United Kingdom population. 61
25232254 2014
91
Interleukin 17A rs3819024 A>G polymorphism is associated with an increased risk of gastric cardia adenocarcinoma in a Chinese population. 61
24893702 2014
92
Shorter dinner-to-bed time is associated with gastric cardia adenocarcinoma risk partly in a reflux-dependent manner. 61
24866433 2014
93
PLCE1 mRNA and protein expression and survival of patients with esophageal squamous cell carcinoma and gastric adenocarcinoma. 61
24867265 2014
94
Microarray expression profile analysis of long non-coding RNAs of advanced stage human gastric cardia adenocarcinoma. 61
24414129 2014
95
Differential expression of Pim-3, c-Myc, and p-p27 proteins in adenocarcinomas of the gastric cardia and distal stomach. 61
24488669 2014
96
A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer. 61
24595006 2014
97
Association between gastric cardia adenocarcinoma risk and alcohol flushing response, but not alcohol consumption. 61
24477652 2014
98
Intakes of folate, methionine, vitamin B6, and vitamin B12 with risk of esophageal and gastric cancer in a large cohort study. 61
24481406 2014
99
Clinical Efficacy of Endoscopic Submucosal Dissection for Adenocarcinomas of the Esophagogastric Junction. 61
26134607 2014
100
The association between physical activity and gastroesophageal cancer: systematic review and meta-analysis. 61
24705782 2014
101
Family history of cancer and gastroesophageal disorders and risk of esophageal and gastric adenocarcinomas: a case-control study. 61
24495377 2014
102
Different roles for p16(INK) (4a) -Rb pathway and INK4a/ARF methylation between adenocarcinomas of gastric cardia and distal stomach. 61
25123601 2014
103
A prospective study of vitamin and mineral supplement use and the risk of upper gastrointestinal cancers. 61
24558423 2014
104
Cutaneous metastasis of gastric cardia adenocarcinoma in a patient: a case report. 61
24753779 2014
105
Methylation-mediated repression of GADD45A and GADD45G expression in gastric cardia adenocarcinoma. 61
23616123 2013
106
Genetic variations of mTORC1 genes and risk of gastric cancer in an Eastern Chinese population. 61
23423739 2013
107
[Analysis of the clinicopathologic characters and prognostic impact of extranodal metastasis in gastric cardia patients]. 61
24433764 2013
108
Expression of Das-1, Ki67 and sulfuric proteins in gastric cardia adenocarcinoma and intestinal metaplasia lesions. 61
23837030 2013
109
Upper gastrointestinal cancer and reflux disease. 61
23844321 2013
110
Risk factors for rising incidence of esophageal and gastric cardia adenocarcinoma. 61
23435833 2013
111
Association of tooth loss and oral hygiene with risk of gastric adenocarcinoma. 61
23503651 2013
112
Polymorphism of A133S and promoter hypermethylation in Ras association domain family 1A gene (RASSF1A) is associated with risk of esophageal and gastric cardia cancers in Chinese population from high incidence area in northern China. 61
23705663 2013
113
Different expression pattern and significance of p14ARF-Mdm2-p53 pathway and Bmi-1 exist between gastric cardia and distal gastric adenocarcinoma. 61
23159155 2013
114
Common genetic variants in the 9p21 region and their associations with multiple tumours. 61
23361049 2013
115
A meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma. 61
22898040 2013
116
Coexistence of gastrointestinal stromal tumor, esophageal and gastric cardia carcinomas. 61
23569349 2013
117
Aberrant methylation and loss expression of RKIP is associated with tumor progression and poor prognosis in gastric cardia adenocarcinoma. 61
22983529 2013
118
Genetic and epigenetic alterations of WWOX in the development of gastric cardia adenocarcinoma. 61
23197378 2013
119
Potentially functional polymorphisms in the CASP7 gene contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population. 61
24040159 2013
120
Physical activity and sedentary behavior in relation to esophageal and gastric cancers in the NIH-AARP cohort. 61
24367697 2013
121
Despite shared susceptibility loci, esophageal squamous cell carcinoma embraces more familial cancer than gastric cardia adenocarcinoma in the Taihang Mountains high-risk region of northern central China. 61
23286478 2013
122
Gastric cardia adenocarcinoma pathway analysis. 61
24834279 2013
123
Esophageal squamous cell carcinoma and gastric cardia adenocarcinoma shared susceptibility locus in PLCE1: a meta-analysis. 61
23874915 2013
124
Dietary N-nitroso compounds, endogenous nitrosation, and the risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study. 61
23193003 2013
125
Higher prevalence of obesity in gastric cardia adenocarcinoma compared to gastric non-cardia adenocarcinoma. 61
22484493 2012
126
Concordant repression and aberrant methylation of transforming growth factor-beta signaling pathway genes occurs early in gastric cardia adenocarcinoma. 61
22722999 2012
127
A prospective cohort study of obesity and risk of oesophageal and gastric adenocarcinoma in the NIH-AARP Diet and Health Study. 61
22174193 2012
128
Replication study of PLCE1 and C20orf54 polymorphism and risk of esophageal cancer in a Chinese population. 61
22744421 2012
129
Diabetes and risk of esophageal and gastric adenocarcinomas. 61
22161620 2012
130
Meta-analysis: risk of esophageal adenocarcinoma with medications which relax the lower esophageal sphincter. 61
22129441 2012
131
Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands. 61
22317953 2012
132
Aspirin and cancer risk: a quantitative review to 2011. 61
22517822 2012
133
Association of polymorphisms in transforming growth factor-β receptors with susceptibility to gastric cardia adenocarcinoma. 61
21785915 2012
134
A meta-analysis on alcohol drinking and esophageal and gastric cardia adenocarcinoma risk. 61
21551004 2012
135
Expression of the c-Met proto-oncogene and Integrin α5β1 in human gastric cardia adenocarcinoma. 61
22976495 2012
136
Detection and clinical significance of lymph node micrometastasis in gastric cardia adenocarcinoma. 61
22429368 2012
137
Potentially functional variants of PLCE1 identified by GWASs contribute to gastric adenocarcinoma susceptibility in an eastern Chinese population. 61
22412849 2012
138
Epidemic trends of obesity with impact on metabolism and digestive diseases. 61
22722428 2012
139
Polymorphisms in ERCC1 and XPF genes and risk of gastric cancer in an eastern Chinese population. 61
23166636 2012
140
Diverging trends in recent population-based survival rates in oesophageal and gastric cancer. 61
22815994 2012
141
Vegetables and fruits consumption and risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study. 61
21960262 2011
142
Serum thyroglobulin, a biomarker for iodine deficiency, is not associated with increased risk of upper gastrointestinal cancers in a large Chinese cohort. 61
21105043 2011
143
Principal component analysis of dietary and lifestyle patterns in relation to risk of subtypes of esophageal and gastric cancer. 61
21435900 2011
144
Aberrant methylation of the CpG island of HLTF gene in gastric cardia adenocarcinoma and dysplasia. 61
21531217 2011
145
Polymorphisms of transforming growth factor-β1 associated with increased risk of gastric cardia adenocarcinoma in north China. 61
21205231 2011
146
Association between novel PLCE1 variants identified in published esophageal cancer genome-wide association studies and risk of squamous cell carcinoma of the head and neck. 61
21689432 2011
147
Genetic variants at 1q22 and 10q23 reproducibly associated with gastric cancer susceptibility in a Chinese population. 61
21427165 2011
148
Prospective study of self-reported diabetes and risk of upper gastrointestinal cancers. 61
21415356 2011
149
Tobacco smoking and esophageal and gastric cardia adenocarcinoma: a meta-analysis. 61
21330928 2011
150
A population-based analysis of esophageal and gastric cardia adenocarcinomas in Ontario, Canada: incidence, risk factors, and regional variation. 61
21409602 2011
151
Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma--a systematic review and meta-analysis. 61
20860989 2011
152
Association of candidate genetic variations with gastric cardia adenocarcinoma in Chinese population: a multiple interaction analysis. 61
21148629 2011
153
Hypermethylation and aberrant expression of Wnt-antagonist family genes in gastric cardia adenocarcinoma. 61
21275459 2011
154
Smoking and COX-2 functional polymorphisms interact to increase the risk of gastric cardia adenocarcinoma in Chinese population. 61
21779349 2011
155
Human papillomavirus DNA and P16(INK4A) expression in concurrent esophageal and gastric cardia cancers. 61
21155014 2010
156
Helicobacter pylori infection may be implicated in the topography and geographic variation of upper gastrointestinal cancers in the Taihang Mountain high-risk region in northern China. 61
21083747 2010
157
Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. 61
20729853 2010
158
A positive family history of esophageal/gastric cardia cancer with gastric cardia adenocarcinoma is associated with a younger age at onset and more likely with another synchronous esophageal/gastric cardia cancer in a Chinese high-risk area. 61
20603233 2010
159
Comparative outcome of oesophagogastric cancer in younger patients. 61
20522292 2010
160
Endobronchial metastasis from adenocarcinoma of gastric cardia 7 years after potentially curable resection. 61
21160887 2010
161
Prognostic value of p53 mutations in oesophageal adenocarcinoma: final results of a 15-year prospective study. 61
20227286 2010
162
Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study. 61
20006613 2010
163
The gastric cardia is not a target for human papillomavirus-induced carcinogenesis. 61
20332262 2010
164
Gastric cardia adenocarcinoma in Taiwanese men: positive associations due to selection bias. 61
20333802 2010
165
[Trend analysis for clinical characteristics and prognosis of adenocarcinoma of cardia]. 61
20038318 2010
166
Aberrant methylation of thrombospondin-1 and its association with reduced expression in gastric cardia adenocarcinoma. 61
20300551 2010
167
Alcohol consumption, cigarette smoking and risk of subtypes of oesophageal and gastric cancer: a prospective cohort study. 61
19828467 2010
168
Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China. 61
19562509 2010
169
Etiology and risk factors for esophageal carcinoma. 61
21088416 2010
170
[Correlation of hypermethylation of TSP1 gene with TGF-beta1 level and T cell immunity in gastric cardia adenocarcinoma]. 61
19958625 2009
171
IGF2R polymorphisms and risk of esophageal and gastric adenocarcinomas. 61
19626700 2009
172
Association between Helicobacter pylori seropositivity and digestive tract cancers. 61
19916178 2009
173
Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China. 61
19656375 2009
174
Vitamin E intake and risk of esophageal and gastric cancers in the NIH-AARP Diet and Health Study. 61
19326432 2009
175
Serum pepsinogens and risk of gastric and oesophageal cancers in the General Population Nutrition Intervention Trial cohort. 61
19136509 2009
176
Aberrant CpG island hypermethylation of RASSF1A in gastric cardia adenocarcinoma. 61
19160099 2009
177
Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression. 61
18989634 2009
178
Physical activity and esophageal and gastric carcinoma in a large prospective study. 61
19062237 2009
179
An investigation on the polymorphisms of two DNA repair genes and susceptibility to ESCC and GCA of high-incidence region in northern China. 61
18046624 2009
180
Changing incidence of gastric and oesophageal cancer subtypes in central Switzerland between 1982 and 2007. 61
19669623 2009
181
Esophageal and gastric cardia cancers on 4238 Chinese patients residing in municipal and rural regions: a histopathological comparison during 24-year period. 61
18566857 2008
182
Food group intake and risk of subtypes of esophageal and gastric cancer. 61
18537156 2008
183
Treatment and survival in a population-based sample of patients diagnosed with gastroesophageal adenocarcinoma. 61
18506920 2008
184
Trends in incidence of esophageal and gastric cardia cancer in high-risk areas in China. 61
18287862 2008
185
A prospective study of BMI and risk of oesophageal and gastric adenocarcinoma. 61
18221867 2008
186
Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County. 61
18187391 2008
187
Alcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomas. 61
17665311 2007
188
[Natural progression of early stage adenocarcinoma of gastric cardia: a report of seventeen cases]. 61
17991310 2007
189
Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study. 61
17337464 2007
190
Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancers. 61
17644046 2007
191
Proteome analysis of human gastric cardia adenocarcinoma by laser capture microdissection. 61
17927838 2007
192
Meta-analysis of antioxidant intake and the risk of esophageal and gastric cardia adenocarcinoma. 61
17581269 2007
193
Fiber intake and risk of adenocarcinomas of the esophagus and stomach. 61
17562192 2007
194
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. 61
17693134 2007
195
Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer. 61
17638920 2007
196
A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. 61
17420181 2007
197
Association of MTHFR C677T and SHMT(1) C1420T with susceptibility to ESCC and GCA in a high incident region of Northern China. 61
17206530 2007
198
Incidence of carcinoma of the oesophagus and gastric cardia. Changes over time and geographical differences. 61
17851842 2007
199
Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. 61
16785284 2006
200
Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. 61
17030196 2006
201
The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden. 61
16571649 2006
202
Self-reported goiter is associated with a significantly increased risk of gastric noncardia adenocarcinoma in a large population-based Chinese cohort. 61
16642482 2006
203
Adenosine diphosphate ribosyl transferase and x-ray repair cross-complementing 1 polymorphisms in gastric cardia cancer. 61
16890595 2006
204
Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China. 61
16496409 2006
205
Trends in incidence rates of oesophagus and gastric cancer in Italy by subsite and histology, 1986-1997. 61
16772831 2006
206
[Loss of heterozygosity at chromosome 8p21-p23 in adenocarcinoma of gastric cardia]. 61
16818423 2006
207
Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. 61
16702363 2006
208
Increasing incidence of adenocarcinoma of the gastroesophageal junction and distal stomach in Canada -- an epidemiological study from 1964-2002. 61
16609756 2006
209
Comparative genomic hybridization: comparison between esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-incidence area for both cancers in Henan, northern China. 61
17069589 2006
210
Dietary patterns and risk of squamous-cell carcinoma and adenocarcinoma of the esophagus and adenocarcinoma of the gastric cardia: a population-based case-control study in Sweden. 61
16898861 2006
211
Adenocarcinoma of gastric cardia in the elderly: surgical problems and prognostic factors. 61
16127740 2005
212
Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. 61
16061918 2005
213
Significant increase in risk of gastroesophageal cancer is associated with interaction between promoter polymorphisms in thymidylate synthase and serum folate status. 61
15817609 2005
214
Occupational exposures and risk of esophageal and gastric cardia cancers among male Swedish construction workers. 61
16049815 2005
215
[The application of surface-enhanced laser desorption/ionization-time of flight-mass spectrometry in diagnosing dysplasia and chronic atrophic gastric-carditis in population with high risk of gastric-cardia adenocarcinoma]. 61
16194406 2005
216
Histochemical studies on intestinal metaplasia adjacent to gastric cardia adenocarcinoma in subjects at high-incidence area in Henan, north China. 61
16094701 2005
217
Tooth loss is associated with increased risk of gastric non-cardia adenocarcinoma in a cohort of Finnish smokers. 61
16036528 2005
218
Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. 61
15947880 2005
219
Methylenetetrahydrofolate reductase polymorphisms/haplotypes and risk of gastric cancer: a case-control analysis in China. 61
15643524 2005
220
Association of methylenetetrahydrofolate reductase and thymidylate synthase promoter polymorphisms with genetic susceptibility to esophageal and cardia cancer in a Chinese high-risk population. 61
16045580 2005
221
Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer. 61
15533591 2004
222
[Comparative genomic hybridization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma in high-incidence region of esophageal carcinoma, Linzhou Henan]. 61
15583998 2004
223
Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. 61
15598788 2004
224
Incidental detection of tubular esophageal duplication in gastric cardia malignancy. 61
15599010 2004
225
Comparison of comorbidity prevalence in oesophageal and gastric carcinoma patients: a population-based study. 61
15201582 2004
226
Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. 61
14996860 2004
227
Psychosocial working conditions and the risk of esophageal and gastric cardia cancers. 61
15461194 2004
228
Effect of body mass index on adenocarcinoma of gastric cardia. 61
14669307 2003
229
Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. 61
14652285 2003
230
Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma. 61
12942560 2003
231
Population attributable risks of esophageal and gastric cancers. 61
13130116 2003
232
A functional polymorphism in the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk of development but not metastasis of gastric cardia adenocarcinoma. 61
12873995 2003
233
Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. 61
12800215 2003
234
Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. 61
12516104 2003
235
Alterations of p53 and PCNA in cancer and adjacent tissues from concurrent carcinomas of the esophagus and gastric cardia in the same patient in Linzhou, a high incidence area for esophageal cancer in northern China. 61
12508343 2003
236
Continuing rising trend in oesophageal adenocarcinoma. 61
12402314 2002
237
Susceptibility to gastric cardia adenocarcinoma and genetic polymorphisms in methylenetetrahydrofolate reductase in an at-risk Chinese population. 61
12433726 2002
238
Diet, obesity and reflux in the etiology of adenocarcinomas of the esophagus and gastric cardia in humans. 61
12421872 2002
239
Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. 61
12412162 2002
240
Occupation and risk of esophageal and gastric cardia adenocarcinoma. 61
12111686 2002
241
Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression. 61
12173384 2002
242
The epidemiology of gastric cancer. 61
11979413 2002
243
Surveillance and survival in Barrett's adenocarcinomas: a population-based study. 61
11874995 2002
244
Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. 61
11839716 2002
245
Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks. 61
12086406 2002
246
Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. 61
11729107 2001
247
Involvement of cancer-activating genes on chromosomes 7 and 8 in esophageal (Barrett's) and gastric cardia adenocarcinoma. 61
11911252 2001
248
Risk of adenocarcinomas of the oesophagus and gastric cardia in patients hospitalized for asthma. 61
11720467 2001
249
Prospective study of tooth loss and incident esophageal and gastric cancers in China. 61
11714113 2001
250
[Re-surgical treatment for postoperative anastomotic recurrence of adenocarcinoma of gastric cardia]. 61
16201193 2001
251
Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers. 61
11535879 2001
252
Family history of cancer and risk of esophageal and gastric cancers in the United States. 61
11391635 2001
253
Molecular cytogenetic evaluation of gastric cardia adenocarcinoma and precursor lesions. 61
11395372 2001
254
Inverse association between intake of cereal fiber and risk of gastric cardia cancer. 61
11159879 2001
255
Changing trends in gastric carcinoma at a university medical center: a twelve-year retrospective analysis. 61
11154167 2001
256
Drinking hot beverages is not associated with risk of oesophageal cancers in a Western population. 61
11139325 2001
257
Antioxidants and cancers of the esophagus and gastric cardia. 61
10925371 2000
258
Intestinal metaplasia is the probable common precursor of adenocarcinoma in barrett esophagus and adenocarcinoma of the gastric cardia. 61
10861428 2000
259
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. 61
10782657 2000
260
The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. 61
10652424 2000
261
Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia. 61
11525596 2000
262
An inverse relation between cagA-positive strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. 61
10597399 1999
263
Recent time trends in cancer of the oesophagus and gastric cardia in the region of Calvados in France, 1978-1995: a population based study. 61
10643936 1999
264
[Dorsal and lumbar metastases diagnosed by bone scintigraphy in a gastric adenocarcinoma patient]. 61
10611573 1999
265
Tobacco, alcohol and the risk of gastric cancer by sub-site and histologic type. 61
10471531 1999
266
[Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)--report on 370 patients]. 61
10486549 1999
267
Association between body mass and adenocarcinoma of the esophagus and gastric cardia. 61
10375336 1999
268
Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)--report on 370 patients. 61
9869212 1998
269
Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. 61
9827707 1998
270
Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux. 61
9752982 1998
271
Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas. 61
9688144 1998
272
An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. 61
9485003 1998
273
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. 61
9488582 1998
274
Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. 61
9450576 1998
275
Association of adenocarcinoma and squamous cell carcinoma of the esophagus with tobacco-related and other malignancies. 61
9332759 1997
276
Cigarette smoking and esophageal and gastric cardia adenocarcinoma. 61
9293909 1997
277
Esophageal and gastric cardia epithelial cell proliferation in northern Chinese subjects living in a high-incidence area. 61
9589362 1997
278
[The influence on prognosis of intraoperative chemotherapy for adenocarcinoma of gastric cardia]. 61
9206049 1996
279
Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. 61
7742727 1995
280
Lymph node metastasis in patients with adenocarcinoma of gastric cardia. 61
8443744 1993
281
Epidemiological characteristics of adenocarcinoma of the gastric cardia and distal stomach in the United States, 1973-1982. 61
3403124 1988

Variations for Gastric Cardia Adenocarcinoma

Expression for Gastric Cardia Adenocarcinoma

Search GEO for disease gene expression data for Gastric Cardia Adenocarcinoma.

Pathways for Gastric Cardia Adenocarcinoma

Pathways related to Gastric Cardia Adenocarcinoma according to GeneCards Suite gene sharing:

(showing 1, show less)
# Super pathways Score Top Affiliating Genes
1 9.88 TP53 MEG3 HOTAIR

GO Terms for Gastric Cardia Adenocarcinoma

Sources for Gastric Cardia Adenocarcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....